CSF3 and metabolic dysfunction-associated steatotic liver disease: According to the results of DEGs analysis, CSF3 appears to be down-regulated in our samples for both ATH and NAFLD, which agrees with the results of the published studies, being that this under-expression of CSF3 the possible cause of the development of NAFLD and ATH.